Nail Vessel Changes and Lung Disease in Scleroderma
Part of Skin clinical trials.
This study looks at changes in tiny blood vessels under the fingernails and how they relate to lung scarring in people with systemic sclerosis (scleroderma). The goal is to better understand this connection to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of systemic sclerosis (scleroderma).
- You cannot have another autoimmune disease like rheumatoid arthritis, dermatomyositis, or connective tissue disease.
- You must not have congestive heart failure or clubbing (bulbous fingertips).
- You must be a non-smoker.
- You must be able to cooperate for a test that examines the tiny blood vessels at the base of your fingernails.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares skin samples from people with scleroderma and healthy volunteers to understand what goes wrong in the skin. It may help researchers find new treatment targets.
This trial uses a simple 6-minute pegboard ring test to check how well your hands work. It aims to understand hand function in scleroderma and may help find new ways to track your health.
This study looks at whether people with systemic sclerosis (scleroderma) have weakness in the muscles they use to breathe. It aims to find out if measuring these muscles can help detect early breathing problems.
This study looks at tiny blood vessels in the nail area of people with psoriasis using a special microscope. It aims to see if psoriasis affects these vessels, which may help doctors better understand the disease.
This trial studies tiny particles in your blood (extracellular vesicles) to see if they can predict who will develop blood vessel complications or how they respond to treatment. It focuses on people with systemic sclerosis who currently have a low risk of pulmonary hypertension.
This trial uses an ultrasound to check blood flow in the gut of people with scleroderma. It looks for connections between gut blood vessel problems and other effects of the disease.
Hear when a new Systemic Sclerosis (SSc) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.